Latest News about ONCE
Recent news which mentions ONCE
Three Interviews From the J.P. Morgan Healthcare Conference
January 15, 2018
From Motley Fool
Sarepta is making a bold bet on genetic medicine
January 10, 2018
From MarketWatch
Here's Why Sangamo Therapeutics Inc. Stock Soared 438% in 2017
January 09, 2018
From Motley Fool
3 Soaring Gene-Editing Biotech Stocks: Which Is the Best Buy?
January 07, 2018
From Motley Fool
Why This Gene Therapy Pioneer Crashed 29.8% in December
January 06, 2018
From Motley Fool
An $850,000 Cure for Blindness, With a Twist
January 04, 2018
From Motley Fool
From Benzinga
Is This Why Editas Medicine Is Surging Today?
January 02, 2018
From Motley Fool
The FDA Just Approved a Game-Changing Therapy for Blindness
December 19, 2017
Tickers
ONCE
Tags
ONCE
From Motley Fool
New Gene Therapies Could Change Hemophilia Forever
December 19, 2017
From Motley Fool
Barron's Picks And Pans: Alaska Air, AT&T, Netflix, Pepsi, And More
December 17, 2017
From Benzinga
3 Stocks That Could Double Your Money
December 16, 2017
From Motley Fool
Alnylam Gets Some Welcome News
December 15, 2017
From Motley Fool
ASH 2017 Recap: These Were the Big Winners and Losers
December 14, 2017
From Motley Fool
Benzinga's Top Upgrades, Downgrades For December 14, 2017
December 14, 2017
From Benzinga
ASH 2017 Highlights: Gilead, Novartis, Juno, Bluebird Bio And More
December 13, 2017
From Benzinga
3 Reasons Spark Therapeutics Is a Buy After Its Crash
December 12, 2017
From Motley Fool
UBS Loses Conviction In Spark Therapeutics, Downgrades
December 12, 2017
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 12, 2017
December 12, 2017
From Benzinga
42 Biggest Movers From Yesterday
December 11, 2017
From Benzinga
What Happened in the Stock Market Today
December 11, 2017
From Motley Fool
11 Biotech Stocks Moving From ASH 2017
December 11, 2017
From Benzinga
From Benzinga
Analyst: Weakness In Spark Therapeutics Is Overdone
December 11, 2017
From Benzinga
Here's Why Spark Therapeutics, Inc. Is Getting Hammered Today
December 11, 2017
From Motley Fool
From Benzinga
Bluebird Bio rallies, Spark Therapeutics craters after unveiling data at ASH meeting
December 11, 2017
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.